Isonics Appoints Veteran FAA Official and Homeland Security Executive

    Business Editors

    GOLDEN, Colo.--(BUSINESS WIRE)--Jan. 28, 2005--Isonics Corporation (NASDAQ:ISON), committed to the development of next-generation technology for the homeland security and semiconductor markets, has appointed Dennis Koehler, a longtime former executive with the Federal Aviation Administration and a homeland security specialist, to the post of Vice President of Government Sales and Marketing. The announcement was made by James Alexander, Chairman and CEO of Isonics.
    In the position, Mr. Koehler will spearhead marketing and sales efforts of Isonics Homeland Security division targeted at the federal government and other public agencies. He is scheduled to start work at Isonics on Feb. 9, 2005.
    Mr. Koehler brings to Isonics a range of government aviation regulation and management experience. He served in several positions at the FAA between 1976 and 2001, including Division Manager for Southern Region Air Traffic Services, Deputy Director for Air Traffic Services requirements, and Program Director for Airway Facilities and Logistics Management. After leaving the FAA, he worked as Director of Corporate Compliance and Government Affairs for Gate Safe Inc., a provider of specialized security services for the airline industry. Since 2004, he has served as Senior Research Analyst for the Homeland Security Institute, where he was responsible for development of research products for the Department of Homeland Security.
    "Dennis brings Isonics the specific types of expertise and experience in the government marketplace that is crucial to the successful marketing and sales of NeutroTest(TM) and other homeland security products and services," said Mr. Alexander. "His years at the FAA and in the aviation security industry provide him with the contacts and understanding necessary to conduct business effectively within federal and state governments and their agencies."
    In related news from its homeland security division, Isonics has announced that it has continued to make progress in due diligence relating to its planned acquisition of Protection Plus Security Consultants Inc. The Company anticipates finalizing the acquisition by the end of the first calendar quarter.
    Isonics also announced continued progress in its marketing efforts with respect to NeutroTest(TM), the Company's prototype hand-held explosive detection device. The Company has been holding meetings with a range of industry and government officials in the homeland security sector in its efforts to further the commercialization of the product.

    About Isonics Corporation

    Isonics Corporation has three business divisions: (1) Isonics Semiconductor, (2) Isonics Life Sciences, and (3) Homeland Security and Defense. Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. Isonics' Life Sciences division markets and sells isotopes to the health care industry for the imaging and treatment of cancer. Stable isotopes can be thought of as ultra pure materials. This high degree of purification provides enhanced properties as compared to natural materials. Our efforts in the Homeland Security segment are nascent at the present time as we proceed to develop further our neutron-based detection technologies. Additional information may be obtained at the Company's Web site at http://www.isonics.com. A presentation about Isonics' NeutroTest(TM) explosive detection prototype can be found at http://www.tril03.com/isonics/madrid.pdf. A video demonstrating the functioning NeutroTest prototype can be viewed at http://www.trilogy-capital.com.edgesuite.net/.

    Cautionary Statement

    Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the six months ended October 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. Isonics cautions investors that there are currently no commercial NeutroTest products, and no guarantee there will be. Isonics has made no NeutroTest sales and no government agency or other person has expressed an interest in purchasing NeutroTest. There can be no assurance that Isonics will be able to manufacture the NeutroTest for the market at a cost and with capabilities that meet the needs of prospective customers.
    This announcement may contain forward-looking statements made by senior management of Isonics that involve risks and uncertainties, such as statements about plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statements. Actual future results and trends may differ materially from those made in -- or suggested by -- statements made in this announcement due to a variety of factors. Consequently, you should not place undue reliance on any forward-looking statements made in this announcement. For more information about Isonics and risks arising from investing in Isonics, you are directed to the Company's most recent Form 10-KSB filed with the Securities and Exchange Commission.

--30--AMP/la*

CONTACT: Isonics Corporation James E. Alexander, 303-279-7900 or Investor Relations: Trilogy Capital Partners, Inc. for Isonics Corporation Paul Karon, 800-592-6067 paul@trilogy-capital.com

KEYWORD: COLORADO INDUSTRY KEYWORD: AEROSPACE/DEFENSE GOVERNMENT MANAGEMENT CHANGES SOURCE: Isonics Corporation

Copyright Business Wire 2005